In addition to these fibrosis-specific regulators, the main transcriptional regulators of lipid homeostasis (including PPARα and PPARγ) and inflammation (RUNX2 and c-Jun) have also been reported to dictate the fibrotic stage in NASH (Table 1). This evidence concerns the gene PPARG and metabolic dysfunction-associated steatohepatitis.